L & S Advisors Inc - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
L & S Advisors Inc ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$272,000
-91.2%
1,870
-92.8%
0.04%
-87.6%
Q1 2022$3,075,000
-47.5%
25,934
-38.9%
0.36%
-42.3%
Q4 2021$5,854,000
-22.1%
42,478
-21.5%
0.63%
-22.3%
Q3 2021$7,519,000
+25.3%
54,125
-12.4%
0.81%
+25.9%
Q2 2021$5,999,000
+49.2%
61,794
+5.1%
0.64%
+41.4%
Q1 2021$4,020,000
-22.2%
58,811
-2.4%
0.46%
-23.7%
Q4 2020$5,166,000
+27.0%
60,276
-3.7%
0.60%
+7.0%
Q3 2020$4,067,000
-18.9%
62,560
-8.8%
0.56%
-25.3%
Q2 2020$5,013,000
+30.1%
68,563
-39.5%
0.75%
+2.9%
Q1 2020$3,854,000
+8.0%
113,251
+72.8%
0.73%
+59.4%
Q4 2019$3,568,000
+42.3%
65,533
+9.0%
0.46%
+29.9%
Q3 2019$2,508,000
-30.0%
60,126
-26.6%
0.35%
-25.8%
Q2 2019$3,585,000
+64.2%
81,868
+93.0%
0.47%
+60.9%
Q1 2019$2,183,000
+33.8%
42,422
-3.9%
0.29%
-3.9%
Q4 2018$1,632,000
+63.9%
44,140
+66.5%
0.31%
+137.2%
Q3 2018$996,000
+21.9%
26,515
+28.2%
0.13%
-6.5%
Q2 2018$817,00020,6850.14%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders